NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

Clinical trial NCT05005845 · COMPLETED

Trial details

NCT number: NCT05005845
Sponsor: NFlection Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous Neurofibroma Neurofibromatosis 1

Start date: 2021-09-29
Primary completion: 2023-10-02
Enrollment: 199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.